Alcon
Alcon manufactures intraocular lenses, which replace the natural lens removed during cataract surgery. It is the second largest division of Swiss group Novartis.
Alcon operates in more than 75 countries, serving 180 markets and employing more than 24,000 people. The Cork centre manufactures AcrySof® intraocular lenses, the most frequently implanted lenses worldwide.
Technologies and processes featured at the Cork site include mould-tool manufacturing, monomer formulation, casting, curing/polymerization, high precision optical measurement and packaging. Approximately 400 employees work at the site.
Financial Data
-
31st Dec 18 Source: CRO
- €58.7 million turnover
-
€2.3 million
profit - 413 employees
-
31st Dec 17 Source: CRO
- €46.4 million turnover
-
€1.5 million
profit - 404 employees
- 5 more years available »
Ranking
By Turnover
(€58.7 million)- 659th in Top Companies
- 63rd in Pharma
By Employees
(413)- 417th in Top Companies
- 37th in Pharma
- 413
- €58.7 million
Employees
- Jackie Murphy Country Manager
Latest News
- 8:42pm Rolls-Royce seeks bids in England and Wales for site to make small nuclear power plants
- 2:22pm Germany’s Lufthansa in talks to buy 40% stake in Italy’s ITA Airways
- 12:56pm Pay freeze for Aer Lingus ground staff proposed until 2024
- Jan 22 Law firm Mason Hayes & Curran posts 23% surge in fee income to €98m
- Jan 21 US judge rules against Paddy Cosgrave over investment fund dispute